Delivery Order SPE2DB20D9329-SPE2DB22FD4MP
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. Under this IDC, the DLA can issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999, which runs through December 31, 2025. Under this IDC, the DLA can issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including common medications as well as specialized...
- This federal contract award was made by the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 under the DLA's SPE2DB program, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a single-award indefinite delivery contract (IDC) under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a single-award indefinite delivery contract (IDC) valued at up to $499,999,999, which runs through December 31, 2025. Under this IDC, the DLA can issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs,...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. Under this IDC, the DLA can issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including common medications,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award is a single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. Under this IDC, the DLA can issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including both common medications and specialized drugs,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a single-award indefinite delivery contract (IDC) under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. Under this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products, including branded and generic prescription...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a single-award Indefinite Delivery Contract (IDC) under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. Under this IDC, the DLA will issue firm fixed-price delivery orders for DMS Pharmaceutical Group to provide a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a single-award Indefinite Delivery Contract (IDC) valued at up to $499,999,999 that runs through December 31, 2025. Under this IDC, the DLA can issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including common medications,...
- SPE2DB20D9329Indefinite Delivery Contract
- SPE2DB20D9329-SPE2DB22FD4MPDelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a single-award indefinite delivery contract (IDC) under the SPE2DB program, valued at up to $499,999,999 and running through December 31, 2025. Under this IDC, the DLA can issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including common medications as well as specialized drugs and medical supplies, to fulfill the recurring medical supply needs of military health facilities worldwide. The contract covers the delivery of a wide variety of pharmaceutical products, from flumazenil injections and prednisone tablets to oncology drugs and specialty medications. This IDC complements DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to Department of Defense (DoD) sites, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 5/10/22 |